Not so long ago, scientists developed a way to eliminate cancer that sets up the body to fight the malignant process on its own. The technique began to attract acute attention when more than 90% of lethally ill patients went into remission.
The therapeutic procedure involves removing white blood cells from the patient’s blood, which are then subjected to modification and returned to the circulatory system. To clarify, immune cells affected by a viral or cancerous process (T-killers) are taken.
These cells then lend themselves to modification, thereby readjusting to recognize and block the pathological process. The reprogrammed cells are introduced into the body’s circulatory system and begin to work naturally, without outside interference.
So far, in clinical practice, this technique is practiced as an experimental and is offered in those cases where other types of treatment have proved ineffective. The final outcome is astonishingly effective – more than 90% of cases are marked by complete remission, where there are no cells affected by the cancer.
As noted by leading international scientists, the methodology is encouraging, but it is only the beginning. According to experts, the main challenge today is how to convert such a treatment principle suitable for other types of cancer.
